Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€0.47

€0.47

-3.510%
-0.017
-3.510%
-
 
12.06.25 / Stuttgart Stock Exchange WKN: A3DTUQ / Name: Vidac Pharma Holding Plc / Stock / ? /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Vidac Pharma Holding Plc Stock

Vidac Pharma Holding Plc took a tumble today and lost -€0.017 (-3.510%).
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Vidac Pharma Holding Plc stock. Negative votes have not been in the majority for any criteria for this stock

Pros and Cons of Vidac Pharma Holding Plc in the next few years

Pros
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Cons
?
G***** c******* t* c**********
?
B****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'

News

U.S. grants broader patent to Vidac Pharma’s oncology drug candidates, adding range of new indications including prostate and pancreatic cancer
U.S. grants broader patent to Vidac Pharma’s oncology drug candidates, adding range of new indications including prostate and pancreatic cancer

-          U.S. patent office widens patent to include broad range of new cancer indications including prostate, pancreatic, lung, cervical and colon cancer

-          Vidac on track to meet